Nanosonics Limited

ASX:NAN Stock Report

Market Cap: AU$975.7m

Nanosonics Valuation

Is NAN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of NAN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: NAN (A$3.22) is trading below our estimate of fair value (A$5.11)

Significantly Below Fair Value: NAN is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for NAN?

Other financial metrics that can be useful for relative valuation.

NAN key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue5x
Enterprise Value/EBITDA65.3x
PEG Ratio3.4x

Price to Earnings Ratio vs Peers

How does NAN's PE Ratio compare to its peers?

The above table shows the PE ratio for NAN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average34.1x
SDI SDI
10.8x-2.1%AU$112.3m
ANN Ansell
37.9x22.1%AU$4.3b
PGC Paragon Care
53x33.1%AU$678.7m
ACL Australian Clinical Labs
34.6x21.0%AU$533.3m
NAN Nanosonics
75.2x22.3%AU$975.7m

Price-To-Earnings vs Peers: NAN is expensive based on its Price-To-Earnings Ratio (75.2x) compared to the peer average (32.3x).

Price to Earnings Ratio vs Industry

How does NAN's PE Ratio compare vs other companies in the Global Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a16.0%
 n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a16.0%
 n/an/an/a
No more companies

Price-To-Earnings vs Industry: NAN is expensive based on its Price-To-Earnings Ratio (75.2x) compared to the Global Medical Equipment industry average (25.9x).

Price to Earnings Ratio vs Fair Ratio

What is NAN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

NAN PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio75.2x
Fair PE Ratio41.1x

Price-To-Earnings vs Fair Ratio: NAN is expensive based on its Price-To-Earnings Ratio (75.2x) compared to the estimated Fair Price-To-Earnings Ratio (41.1x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst NAN forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentAU$3.22
AU$3.40
+5.7%
14.9%AU$4.20AU$2.55n/a12
Aug ’25AU$3.20
AU$3.33
+4.2%
16.8%AU$4.20AU$2.55n/a12
Jul ’25AU$2.87
AU$3.20
+11.6%
16.4%AU$4.20AU$2.55n/a12
Jun ’25AU$2.81
AU$3.20
+14.0%
16.4%AU$4.20AU$2.55n/a12
May ’25AU$2.83
AU$3.20
+13.2%
16.4%AU$4.20AU$2.55n/a12
Apr ’25AU$2.75
AU$3.20
+16.5%
16.4%AU$4.20AU$2.55n/a12
Mar ’25AU$2.77
AU$3.20
+15.7%
16.4%AU$4.20AU$2.55n/a12
Feb ’25AU$2.90
AU$3.75
+29.3%
15.6%AU$5.00AU$2.83n/a11
Jan ’25AU$4.40
AU$4.56
+3.7%
14.7%AU$5.46AU$3.65n/a12
Dec ’24AU$4.11
AU$4.65
+13.2%
17.9%AU$6.50AU$3.65n/a12
Nov ’24AU$3.86
AU$4.65
+20.5%
17.9%AU$6.50AU$3.65n/a12
Oct ’24AU$4.22
AU$4.69
+11.2%
17.1%AU$6.50AU$3.75n/a12
Sep ’24AU$4.15
AU$4.59
+10.6%
18.6%AU$6.50AU$3.34n/a13
Aug ’24AU$4.78
AU$4.76
-0.3%
17.9%AU$6.50AU$3.34AU$3.2013
Jul ’24AU$4.74
AU$4.72
-0.4%
19.1%AU$6.50AU$3.34AU$2.8712
Jun ’24AU$5.17
AU$4.72
-8.6%
19.1%AU$6.50AU$3.34AU$2.8112
May ’24AU$5.54
AU$4.71
-15.0%
18.8%AU$6.50AU$3.34AU$2.8312
Apr ’24AU$5.09
AU$4.54
-10.7%
15.5%AU$6.00AU$3.34AU$2.7512
Mar ’24AU$4.46
AU$4.45
-0.2%
12.9%AU$5.35AU$3.34AU$2.7712
Feb ’24AU$4.81
AU$4.47
-7.0%
14.3%AU$5.50AU$3.25AU$2.9011
Jan ’24AU$4.29
AU$4.32
+0.7%
16.4%AU$5.50AU$3.25AU$4.4011
Dec ’23AU$4.84
AU$4.32
-10.7%
16.4%AU$5.50AU$3.25AU$4.1111
Nov ’23AU$4.27
AU$4.25
-0.4%
17.6%AU$5.50AU$3.25AU$3.8611
Oct ’23AU$3.46
AU$4.27
+23.3%
17.3%AU$5.50AU$3.25AU$4.2211
Sep ’23AU$4.12
AU$4.16
+1.0%
18.9%AU$5.50AU$3.00AU$4.1512
Aug ’23AU$4.62
AU$4.33
-6.3%
24.8%AU$7.00AU$3.00AU$4.7811

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y